REBECCA STOLORENA: Open Payments
NPI 1083279392 · DENVER, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,123 in 59 payments from 21 companies in 2025. Trend: 2023 $852 · 2024 $1,083 · 2025 $1,123
Food & beverage: $1,123
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $305 |
| ABBVIE INC. | 14 | $182 |
| Lilly USA, LLC | 5 | $106 |
| PFIZER INC. | 3 | $58 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| Abbott Laboratories | 2 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Amgen Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
Products named: Wegovy, MOUNJARO, VRAYLAR, Rybelsus, UBRELVY, Ozempic, Auvelity, FREESTYLE LIBRE 3.
Industry payments across NC — which companies pay providers there.
